RESULTS	More patients achieved `` absent '' or `` very mild '' disease at week 8 with the two-compound scalp formulation ( 71.2 % ) compared with betamethasone dipropionate in the same vehicle ( 64.0 % , p = .011 ) , calcipotriene in the same vehicle ( 36.8 % , p < .0001 ) , or the vehicle ( 22.8 % , p < .0001 ) .\